Synairgen (LON:SNG) Stock Price Down 17.8% – Here’s Why

Synairgen plc (LON:SNGGet Free Report) traded down 17.8% during mid-day trading on Friday . The company traded as low as GBX 2.10 ($0.03) and last traded at GBX 2.10 ($0.03). 549,758 shares changed hands during mid-day trading, an increase of 63% from the average session volume of 337,550 shares. The stock had previously closed at GBX 2.56 ($0.03).

Synairgen Stock Down 2.5 %

The company has a current ratio of 6.77, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09. The business’s fifty day moving average price is GBX 4.25 and its two-hundred day moving average price is GBX 4.26. The firm has a market cap of £5.01 million, a P/E ratio of -83.00 and a beta of -2.23.

About Synairgen

(Get Free Report)

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.

See Also

Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.